Search

everythinglearnresearchcommunity

for

Search:↓

The immune processes causing VKH and vitiligo are similar in dogs and humans.

Biologics show promise in treating various stubborn skin diseases, but more research and better reimbursement criteria are needed.

Soluble CD83 speeds up wound healing and reduces scarring.

Bone marrow-derived stem cells improved healing and reduced scarring in second-degree burns in rats.

Blocking certain immune signals can reduce skin damage from radiation therapy.

Skin cells release substances important for healing and fighting infection, and understanding these could improve skin disorder treatments.

JAK inhibitors are effective for treating moderate-to-severe alopecia areata.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

New treatments like biologics and JAK inhibitors show promise for severe scalp inflammation when traditional methods fail.

Periplaneta americana extract helps hair regrowth by reducing inflammation and improving skin bacteria balance.

CGF therapy may effectively treat psoriasis by reducing inflammation.

Personalized medicine in dermatology uses molecular biomarkers to improve diagnosis and treatment but needs further advancements for practical use.

Secukinumab reduces immune activity in hidradenitis suppurativa skin.

A patient with PPP had rare skin reactions to adalimumab, which improved after stopping smoking and continuing acitretin.

17β-estradiol can reduce inflammation in the skin.

Biologics and small molecules can effectively treat inflammatory nail disorders, but personalized treatment plans are important.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

New small molecule drugs show promise in treating complex skin diseases but need more safety research.

The document concludes that new treatments for skin conditions are complex but effective, including spironolactone for female hair loss and propranolol for infantile hemangiomas.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

NDP-MSH protects brain cells and reduces inflammation in Parkinson's disease by activating MC1R and involving Tregs.

Fibronectin is essential for hair follicle regeneration by supporting stem cells.

More precise, personalized therapies are needed for autoimmune diseases.

Cedrol may help treat rheumatoid arthritis due to its anti-inflammatory and antioxidant effects.

IBD treatment is complex and requires personalized approaches due to varying patient responses.

Dupilumab and ustekinumab are promising treatments for alopecia areata, showing significant hair regrowth.

EGF receptor is crucial for skin health and its inhibitors can cause skin rashes.

Blocking EGFR can cause skin inflammation by disrupting IL-1 signaling.

Xinyang Tablet improves heart function in sepsis by reducing inflammation.